SERIES A ORDINARY SHARES PURCHASE WARRANT ROSETTA GENOMICS LTD.Security Agreement • November 30th, 2010 • Rosetta Genomics Ltd. • Pharmaceutical preparations
THIS SERIES A ORDINARY SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the fifth year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rosetta Genomics Ltd., a company organized under the laws of the State of Israel (the “Company”), up to ______ Ordinary Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 30th, 2010 • Rosetta Genomics Ltd. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of November 29, 2010, between Rosetta Genomics Ltd., a company organized under the laws of the State of Israel (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
SERIES B ORDINARY SHARES PURCHASE WARRANT ROSETTA GENOMICS LTD.Security Agreement • November 30th, 2010 • Rosetta Genomics Ltd. • Pharmaceutical preparations
THIS SERIES B ORDINARY SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, on the 33rd Trading Day following the Effective Date (as defined in the Purchase Agreement) (the “Exercise Date”) to receive from Rosetta Genomics Ltd., a company organized under the laws of the State of Israel (the “Company”), up to ______ Ordinary Shares (as subject to adjustment hereunder, the “Warrant Shares”) according to the vesting schedule set forth below. The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b) and shall be exercised only via cashless exercise pursuant to Section 2(c) below. On the Exercise Date a number of Warrant Shares shall vest under this Warrant equal to the product of (a) the maximum number of Warrant Shares issuable under this Warrant
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 30th, 2010 • Rosetta Genomics Ltd. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of November 29, 2010, between Rosetta Genomics Ltd., a company organized under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
